Company overview
Barkan-Farma specializes in the development, production and marketing of ethical drugs in the Eastern European and Central Asia regions.
Barkan-Farma S.R.L. is a privately held pharmaceutical company established in 2007 in Moldova. The Company was started by two successful Israeli entrepreneurs Mr. Rafi Barkan and Mr. Zinovi Heifetz. Mr. Barkan is the founder of the renowned R&D company Meditor Pharmaceuticals Ltd., that has developed a true breakthrough in the migraine treatment.
Barkan-Farma S.R.L. is a unique ethical drug company. The Company's mission is to serve the unmet needs of the chosen Eastern European and Central Asia pharmaceutical markets while capitalizing on their untapped market opportunity and outstanding market growth potential.
Barkan-Farma is committed to developing therapeutic advancements for a range of disorders with unmet medical needs. The Company’s development pipeline is initially focused on the migraine treatment, surgery related hypotension, menorrhagia and nasal congestion therapies. This products pipeline alone addresses more than US $ 1 billion opportunity in the Eastern European and Central Asia regions markets.
The Company's goals and long-term objectives are:
• To establish corporate identity and build the image of a trusted ethical drug company
• To develop a highly reputable, well-recognized brand for its ethical anti-migraine drug
• To develop distinctive local brands for other hypotension disorders related therapies
• To build a robust and well-developed distribution network in each of the target countries
• To develop a distinctive portfolio of generic drugs, cosmeceuticals and unique dietary supplement products. By doing so the Company will further grow its sales and profitability, utilizing the established distribution network and capitalizing on the image of the highly reputable ethical drug company.
